Elena Christine Vasti, MD
Internal Medicine · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Vasti’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A178421 · Current
Licensed to practise in California · since 2022 · expires 2028-07-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Drugs they prescribed that Part D paid
$29,645
Pharmacies billed $29,645 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 87) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
51 generic and 36 brand-name prescriptions · $29,645 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $7,505 | $682 |
| Spironolactone | 11 | $143 | $13 |
| Furosemide | 15 | $118 | $8 |
Year by year
| 2024 | 87 | 17 | 0% (0) | 41% | $29,645 |
| 2023 | 53 | 17 | 0% (0) | 38% | $21,220 |
| 2022 | 39 | 11 | 0% (0) | None | $5,193 |
| 2021 | 30 | 13 | None | None | $1,307 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Levothyroxine | 11 | $118 | $11 |
| Atorvastatin | 11 | $92 | $8 |
Money from drug and device companies
$1,083 in 2025
| 2025 | 1 | 7 | None | $1,083 |
| 2024 | 2 | 13 | None | $2,211 |
| 2022 | 1 | 1 | None | $70 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CVRx | Barostim Neo System | $1,083 | 7 payments
|
See all 7 published payments
| CVRx | Travel · 2025-05-09 | Barostim Neo System | $430 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $31 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $78 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $78 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $102 |
| CVRx | Travel · 2025-04-18 | Barostim Neo System | $68 |
| CVRx | Travel · 2025-04-18 | Barostim Neo System | $296 |
See earlier years (2024, 2022)
2024: $2,211
| CVRx | Barostim Neo System | $1,227 | 10 payments
|
| Medtronic | None | $984 | 3 payments
|
2022: $70
| AstraZeneca Pharmaceuticals LP | None | $70 | 1 payment
|
Professional record
- NPI
- 1386107555
- Licence
- CA A178421California A178421: Current · expires 2028-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2019-04-12
- NPI last updated
- 2022-07-01
- NPI record certified
- 2022-07-01
This is when the NPI record was last certified, not a medical board exam.